Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Pediatr Pulmonol ; 59(3): 642-651, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38088209

RESUMO

RATIONALE: The use of long-term noninvasive respiratory support is increasing in children along with an extension of indications, in particular in children with central nervous system (CNS) disorders. OBJECTIVE: The aim of this study was to describe the characteristics of children with CNS disorders treated with long-term noninvasive respiratory support in France. METHODS: Data were collected from 27 French pediatric university centers through an anonymous questionnaire filled for every child treated with noninvasive ventilatory support ≥3 months on 1st June 2019. MAIN RESULTS: The data of 182 patients (55% boys, median age: 10.2 [5.4;14.8] years old [range: 0.3-25]) were collected: 35 (19%) patients had nontumoral spinal cord injury, 22 (12%) CNS tumors, 63 (35%) multiple disabilities, 26 (14%) central alveolar hypoventilation and 36 (20%) other CNS disorders. Seventy five percent of the patients were treated with noninvasive ventilation (NIV) and 25% with continuous positive airway pressure (CPAP). The main investigations performed before CPAP/NIV initiation were nocturnal gas exchange recordings, alone or coupled with poly(somno)graphy (in 29% and 34% of the patients, respectively). CPAP/NIV was started in an acute setting in 10% of the patients. Median adherence was 8 [6;10] hours/night, with 12% of patients using treatment <4 h/day. Nasal mask was the most common interface (70%). Airway clearance techniques were used by 31% of patients. CONCLUSION: CPAP/NIV may be a therapeutic option in children with CNS disorders. Future studies should assess treatment efficacy and patient reported outcome measures.


Assuntos
Doenças do Sistema Nervoso Central , Ventilação não Invasiva , Apneia do Sono Tipo Central , Masculino , Criança , Humanos , Adolescente , Feminino , Ventilação não Invasiva/métodos , Pressão Positiva Contínua nas Vias Aéreas/métodos , Resultado do Tratamento , Doenças do Sistema Nervoso Central/complicações , Doenças do Sistema Nervoso Central/terapia
2.
Neuromuscul Disord ; 32(11-12): 886-892, 2022 12.
Artigo em Inglês | MEDLINE | ID: mdl-36270935

RESUMO

The aim of the study was to describe the characteristics of children with neuromuscular diseases treated with long term noninvasive ventilation or continuous positive airway pressure in France. On June 1st 2019, 387 patients (63% boys, mean age 11.2 ± 5.5 years) were treated with long term noninvasive ventilation/continuous positive airway pressure. Thirty three percent of patients had spinal muscular atrophy, 30% congenital myopathy/dystrophy, 20% Duchenne muscular dystrophy, 7% Steinert myotonic dystrophy, and 9% other neuromuscular diseases. Ninety-four percent of patients were treated with long term noninvasive ventilation and 6% with continuous positive airway pressure. Treatment was initiated electively for 85% of patients, mainly on an abnormal overnight gas exchange recording (38% of patients). Noninvasive ventilation/continuous positive airway pressure was initiated during a respiratory exacerbation in 15% of patients. Mean duration of noninvasive ventilation/continuous positive airway pressure was 3.3 ± 3.1 years. Mean objective long term noninvasive ventilation/continuous positive airway pressure use was 8.0 ± 3.1 h/24. Spinal muscular atrophy, congenital myopathy/dystrophy, and Duchenne muscular dystrophy represented 83% of children with neuromuscular diseases treated with long term noninvasive ventilation in France. Screening for nocturnal hypoventilation was satisfactory as noninvasive ventilation /continuous positive airway pressure was predominantly initiated electively.


Assuntos
Atrofia Muscular Espinal , Distrofia Muscular de Duchenne , Doenças Neuromusculares , Ventilação não Invasiva , Masculino , Criança , Humanos , Pré-Escolar , Adolescente , Feminino , Pressão Positiva Contínua nas Vias Aéreas , Distrofia Muscular de Duchenne/complicações , Distrofia Muscular de Duchenne/terapia , Doenças Neuromusculares/complicações , Doenças Neuromusculares/terapia
3.
Respir Med ; 181: 106388, 2021 05.
Artigo em Inglês | MEDLINE | ID: mdl-33848922

RESUMO

OBJECTIVE: To describe the characteristics of children treated with long term continuous positive airway pressure (CPAP) or noninvasive ventilation (NIV) in France. DESIGN: Cross-sectional national survey. SETTING: Paediatric CPAP/NIV teams of 28 tertiary university hospitals in France. PATIENTS: Children aged <20 years treated with CPAP/NIV since at least 3 months on June 1st, 2019. INTERVENTION: An anonymous questionnaire was filled in for every patient. RESULTS: The data of 1447 patients (60% boys), mean age 9.8 ± 5.8 years were analysed. The most frequent underlying disorders were: upper airway obstruction (46%), neuromuscular disease (28%), disorder of the central nervous system (13%), cardiorespiratory disorder (7%), and congenital bone disease (4%). Forty-five percent of the patients were treated with CPAP and 55% with NIV. Treatment was initiated electively for 92% of children, while 8% started during an acute illness. A poly(somno)graphy (P(S)G) was performed prior to treatment initiation in 26%, 36% had a P(S)G with transcutaneous carbon dioxide monitoring (PtcCO2), while 23% had only a pulse oximetry (SpO2) with PtcCO2 recording. The decision of CPAP/NIV initiation during an elective setting was based on the apnea-hypopnea index (AHI) in 41% of patients, SpO2 and PtcCO2 in 25% of patients, and AHI with PtcCO2 in 25% of patients. Objective adherence was excellent with a mean use of 7.6 ± 3.2 h/night. Duration of CPAP/NIV was 2.7 ± 2.9 years at the time of the survey. CONCLUSION: This survey shows the large number of children treated with long term CPAP/NIV in France with numerous children having disorders other than neuromuscular diseases.


Assuntos
Pressão Positiva Contínua nas Vias Aéreas , Ventilação não Invasiva , Adolescente , Fatores Etários , Obstrução das Vias Respiratórias/terapia , Criança , Pré-Escolar , Pressão Positiva Contínua nas Vias Aéreas/estatística & dados numéricos , Estudos Transversais , Feminino , França/epidemiologia , Humanos , Lactente , Masculino , Ventilação não Invasiva/estatística & dados numéricos , Cooperação do Paciente/estatística & dados numéricos , Síndromes da Apneia do Sono/terapia , Inquéritos e Questionários , Fatores de Tempo , Adulto Jovem
4.
J Clin Sleep Med ; 13(9): 1105-1108, 2017 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-28558865

RESUMO

ABSTRACT: Selenoprotein-related myopathy (SEPN1-RM) is a rare disease with a variable clinical presentation. The selenoprotein N1 gene (SEPN1) mutation causing this congenital muscular dystrophy was identified in 2001. Sleep-disordered breathing (SDB) may occur in young patients with SEPN1-RM who are still able to walk. We report the cases of two children with SEPN1-RM who presented with SDB at the ages of 7 and 12 years and for whom long-term nocturnal noninvasive ventilation yielded significant improvement. Based on literature review and our current cases, it seems that there is no obvious relationship between the time since SDB onset and outcome of pulmonary function tests or limb muscle weakness. We therefore suggest that SDB should be systematically screened for in patients with SEPN1-RM, at regular intervals using nocturnal polysomnography.


Assuntos
Proteínas Musculares/genética , Doenças Musculares/complicações , Ventilação não Invasiva/métodos , Selenoproteínas/deficiência , Síndromes da Apneia do Sono/etiologia , Síndromes da Apneia do Sono/terapia , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Doenças Musculares/genética , Mutação/genética , Polissonografia/estatística & dados numéricos , Selenoproteínas/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA